{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T08:18:08Z","timestamp":1793521088450,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,1,17]],"date-time":"2021-01-17T00:00:00Z","timestamp":1610841600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,17]],"date-time":"2021-01-17T00:00:00Z","timestamp":1610841600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>To investigate the course of health-related quality of life (HRQOL) from diagnosis to 2\u00a0years follow-up among patients with oropharyngeal cancer (OPSCC), in relation to human papilloma virus (HPV) status.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This study included 270 OPSCC patients. Age, sex, tumor sublocation, tumor stage, HPV status, treatment modality, comorbidity, smoking, and alcohol use were retrieved from medical records. HPV status was positive when p16 and HPV DNA tests were both positive. HRQOL was assessed using the EORTC QLQ-C30\/QLQ-H&amp;N35 pretreatment and at 6\u00a0weeks, 6, 12, 18, and 24\u00a0months after treatment. To compare the course of HRQOL between patients with an HPV-positive versus HPV-negative tumor, linear and logistic mixed models were used.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Patients with an HPV-positive tumor (29%) were more often male, diagnosed with a tumor of the tonsil or base of the tongue, treated with single treatment, had fewer comorbidities, were less often current smokers and had lower alcohol consumption. Adjusted for confounders, the course of global quality of life, physical, role, and social functioning, fatigue, pain, insomnia, and appetite loss was significantly different: patients with an HPV-positive tumor scored better before treatment, worsened during treatment, and recovered better and faster at follow-up, compared to patients with an HPV-negative tumor. The course of emotional functioning and oral pain was also significantly different between the two groups, but with other trajectories.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The course of HRQOL is different in patients with an HPV-positive tumor versus an HPV-negative tumor, adjusted for sociodemographic, clinical, and lifestyle confounders.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00520-020-05932-w","type":"journal-article","created":{"date-parts":[[2021,1,17]],"date-time":"2021-01-17T07:02:20Z","timestamp":1610866940000},"page":"4473-4483","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["The course of health-related quality of life from diagnosis to two years follow-up in patients with oropharyngeal cancer: does HPV status matter?"],"prefix":"10.1007","volume":"29","author":[{"given":"Laura H. A.","family":"Korsten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Femke","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit I.","family":"Lissenberg-Witte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marije","family":"Vergeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruud H.","family":"Brakenhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Ren\u00e9","family":"Leemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4507-4607","authenticated-orcid":false,"given":"Irma M.","family":"Verdonck-de Leeuw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,17]]},"reference":[{"key":"5932_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69\u201390","journal-title":"CA Cancer J Clin"},{"key":"5932_CR2","first-page":"3282","volume":"48","author":"WJ Blot","year":"1988","unstructured":"Blot WJ, McLaughlin JK, Winn DM, Austin DF, Greenberg RS, Preston-Martin S, Bernstein L, Schoenberg JB, Stemhagen A, Fraumeni JF Jr (1988) Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res 48:3282\u20133287","journal-title":"Cancer Res"},{"key":"5932_CR3","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1159\/000381717","volume":"89","author":"F Pezzuto","year":"2015","unstructured":"Pezzuto F, Buonaguro L, Caponigro F, Ionna F, Starita N, Annunziata C, Buonaguro FM, Tornesello ML (2015) Update on head and neck ancer: current knowledge on epidemiology, risk factors, Molecular Features and Novel Therapies. Oncology 89:125\u2013136","journal-title":"Oncology"},{"key":"5932_CR4","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1158\/1055-9965.EPI-08-0347","volume":"18","author":"M Hashibe","year":"2009","unstructured":"Hashibe M, Brennan P, Chuang SC, Boccia S, Castellsague X, Chen C, Curado MP, Dal Maso L, Daudt AW, Fabianova E, Fernandez L, Wunsch-Filho V, Franceschi S, Hayes RB, Herrero R, Kelsey K, Koifman S, la Vecchia C, Lazarus P, Levi F, Lence JJ, Mates D, Matos E, Menezes A, McClean MD, Muscat J, Eluf-Neto J, Olshan AF, Purdue M, Rudnai P, Schwartz SM, Smith E, Sturgis EM, Szeszenia-Dabrowska N, Talamini R, Wei Q, Winn DM, Shangina O, Pilarska A, Zhang ZF, Ferro G, Berthiller J, Boffetta P (2009) Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the international head and neck cancer epidemiology consortium. Cancer Epidemiol Biomark Prev 18:541\u2013550","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"5932_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nrc2982","volume":"11","author":"CR Leemans","year":"2011","unstructured":"Leemans CR, Braakhuis BJ, Brakenhoff RH (2011) The molecular biology of head and neck cancer. Nat Rev Cancer 11:9\u201322","journal-title":"Nat Rev Cancer"},{"key":"5932_CR6","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1002\/lary.25767","volume":"126","author":"Z Gooi","year":"2016","unstructured":"Gooi Z, Chan JY, Fakhry C (2016) The epidemiology of the human papillomavirus related to oropharyngeal head and neck cancer. Laryngoscope 126:894\u2013900","journal-title":"Laryngoscope"},{"key":"5932_CR7","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1002\/ijc.22851","volume":"121","author":"CC Ragin","year":"2007","unstructured":"Ragin CC, Taioli E (2007) Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis. Int J Cancer 121:1813\u20131820","journal-title":"Int J Cancer"},{"key":"5932_CR8","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1056\/NEJMoa0912217","volume":"363","author":"KK Ang","year":"2010","unstructured":"Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-T\u00e2n PF, Westra WH, Chung CH, Jordan RC, Lu C, Kim H, Axelrod R, Silverman CC, Redmond KP, Gillison ML (2010) Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 363:24\u201335","journal-title":"N Engl J Med"},{"key":"5932_CR9","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/jnci\/djn011","volume":"100","author":"C Fakhry","year":"2008","unstructured":"Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, Pinto H, Forastiere A, Gillison ML (2008) Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 100:261\u2013269","journal-title":"J Natl Cancer Inst"},{"key":"5932_CR10","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1002\/1097-0142(20010815)92:4<805::AID-CNCR1386>3.0.CO;2-9","volume":"92","author":"K Lindel","year":"2001","unstructured":"Lindel K, Beer KT, Laissue J, Greiner RH, Aebersold DM (2001) Human papillomavirus positive squamous cell carcinoma of the oropharynx: a radiosensitive subgroup of head and neck carcinoma. Cancer 92:805\u2013813","journal-title":"Cancer"},{"key":"5932_CR11","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1200\/JCO.2015.62.5970","volume":"34","author":"DI Rosenthal","year":"2016","unstructured":"Rosenthal DI, Harari PM, Giralt J et al (2016) Association of human papillomavirus and p16 status with outcomes in the IMCL-9815 phase III registration trial for patients with locoregionally advanced oropharyngeal squamous cell carcinoma of the head and neck treated with radiotherapy with or without cetuximab. J Clin Oncol 34:1300\u20131308","journal-title":"J Clin Oncol"},{"key":"5932_CR12","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ejca.2017.03.006","volume":"78","author":"H H\u00f8xbroe Michaelsen","year":"2017","unstructured":"H\u00f8xbroe Michaelsen H, Gr\u00f8nh\u00f8j C, H\u00f8xbroe Michaelsen J, Friborg J, von Buchwald C (2017) Quality of life in survivors of oropharyngeal cancer: a systematic review and meta-analysis of 1366 patients. Eur J Cancer 78:91\u2013102","journal-title":"Eur J Cancer"},{"issue":"7","key":"5932_CR13","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.clon.2016.02.012","volume":"28","author":"RH Dodd","year":"2016","unstructured":"Dodd RH, Waller J, Marlow LA (2016) Human papillomavirus and head and neck cancer: psychosocial impact in patients and knowledge of the link - a systematic review. Clin Oncol (R Coll Radiol) 28(7):421\u2013439","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"5932_CR14","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1177\/0194599811434707","volume":"146","author":"A Sharma","year":"2012","unstructured":"Sharma A, Mendez E, Yueh B et al (2012) Human papillomavirus-positive oral cavity and oropharyngeal cancer patients do not have better quality-of-life trajectories. Otolaryngol Head Neck Surg 146:739\u2013745","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"11","key":"5932_CR15","doi-asserted-by":"publisher","first-page":"1099e108","DOI":"10.1001\/jamaoto.2013.2747","volume":"139","author":"PT Dziegielewski","year":"2013","unstructured":"Dziegielewski PT, Teknos TN, Durmus K, Old M, Agrawal A, Kakarala K et al (2013) Transoral robotic surgery for oropharyngeal cancer: long-term quality of life and functional outcomes. JAMA Otolaryngol Head Neck Surg 139(11):1099e108","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"5932_CR16","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/lary.23622","volume":"123","author":"MA Broglie","year":"2013","unstructured":"Broglie MA, Soltermann A, Haile SR, R\u00f6\u00f6sli C, Huber GF, Schmid S, Stoeckli SJ (2013) Quality of life of oropharyngeal cancer patients with respect to treatment strategy and p16-positivity. Laryngoscope 123:164\u2013170","journal-title":"Laryngoscope"},{"key":"5932_CR17","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.ijrobp.2016.03.017","volume":"97","author":"J Ringash","year":"2017","unstructured":"Ringash J, Fisher R, Peters L, Trotti A, O'Sullivan B, Corry J, Kenny L, van den Bogaert W, Wratten C, Rischin D (2017) Effect of p16 status on the quality-of-life experience during chemoradiation for locally advanced oropharyngeal cancer: a substudy of randomized trial trans-Tasman radiation oncology group (TROG) 02.02 (HeadSTART). Int J Radiat Oncol Biol Phys 97:678\u2013686","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"5932_CR18","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3892\/ol.2017.6152","volume":"14","author":"G Spinato","year":"2017","unstructured":"Spinato G, Stellin M, Azzarello G, Bonazza D, Zanconati F, Politi D, Cocuzza S, Di Mauro P, Ausoni S, Tonoli G, Costantini G, Maiolino L, Spinato R, Da Mosto MC, Baboci L, Del Mistro A, Serra A, Tirelli G (2017) Multicenter research into the quality of life of patients with advanced oropharyngeal carcinoma with long-term survival associated with human papilloma virus. Oncol Lett 14(1):185\u2013193","journal-title":"Oncol Lett"},{"key":"5932_CR19","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1002\/lary.24508","volume":"124","author":"JH Maxwell","year":"2014","unstructured":"Maxwell JH, Mehta V, Wang H, Cunningham D, Duvvuri U, Kim S, Johnson J, Ferris RL (2014) Quality of life in head and neck cancer patients: impact of HPV and primary treatment modality. Laryngoscope 124:1592\u20131597","journal-title":"Laryngoscope"},{"issue":"4","key":"5932_CR20","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1007\/s13193-016-0559-4","volume":"7","author":"AK Singh","year":"2016","unstructured":"Singh AK, Kushwaha JK, Anand A, Sonkar AA, Husain N, Srivastava K, Singh S (2016) Human papilloma virus in Oral cavity Cancer and relation to change in quality of life following treatment-a pilot study from northern India. Indian J Surg Oncol 7(4):386\u2013391","journal-title":"Indian J Surg Oncol"},{"issue":"4","key":"5932_CR21","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.ijrobp.2016.07.020","volume":"97","author":"C Xiao","year":"2017","unstructured":"Xiao C, Zhang Q, Nguyen-T\u00e2n PF, List M, Weber RS, Ang KK, Rosenthal D, Filion EJ, Kim H, Silverman C, Raben A, Galloway T, Fortin A, Gore E, Winquist E, Jones CU, Robinson W, Raben D, Le QT, Bruner D (2017) Quality of Life and performance status from a substudy conducted within a prospective phase 3 randomized trial of concurrent standard radiation versus accelerated radiation plus cisplatin for locally advanced head and neck carcinoma: NRG Oncology RTOG 0129. Int J Radiat Oncol Biol Phys 97(4):667\u2013677","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"5932_CR22","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s40463-018-0301-z","volume":"47","author":"HZ Marzouki","year":"2018","unstructured":"Marzouki HZ, Biron VL, Dziegielewski PT, Ma A, Vaz J, Constantinescu G, Harris J, O'Connell D, Seikaly H (2018) The impact of human papillomavirus (HPV) status on functional outcomes and quality of life (QOL) after surgical treatment of oropharyngeal carcinoma with free-flap reconstruction. J Otolaryngol Head Neck Surg 47(1):58","journal-title":"J Otolaryngol Head Neck Surg"},{"issue":"15","key":"5932_CR23","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.1002\/cncr.31537","volume":"124","author":"C Xiao","year":"2018","unstructured":"Xiao C, Beitler JJ, Higgins KA, Glazer T, Huynh LK, Paul S, Felger JC, Wommack EC, Saba NF, Shin DM, Bruner DW, Miller AH (2018) Associations among human papillomavirus, inflammation, and fatigue in patients with head and neck cancer. Cancer. 124(15):3163\u20133170","journal-title":"Cancer."},{"key":"5932_CR24","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1002\/hed.21361","volume":"32","author":"RP Takes","year":"2010","unstructured":"Takes RP, Rinaldo A, Silver CE, Piccirillo JF, Haigentz M Jr, Su\u00e1rez C, van der Poorten V, Hermans R, Rodrigo JP, Devaney KO, Ferlito A (2010) Future of the TNM classification and staging system in head and neck cancer. Head Neck 32:1693\u20131711","journal-title":"Head Neck"},{"key":"5932_CR25","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1001\/archotol.126.9.1086","volume":"126","author":"JF Piccirillo","year":"2000","unstructured":"Piccirillo JF (2000) Impact of comorbidity and symptoms on the prognosis of patients with oral carcinoma. Arch Otolaryngol Head Neck Surg 126:1086\u20131088","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"5932_CR26","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1002\/ijc.27821","volume":"132","author":"MM Rietbergen","year":"2013","unstructured":"Rietbergen MM, Leemans CR, Bloemena E, Heideman DAM, Braakhuis BJM, Hesselink AT, Witte BI, de Jong RJB, Meijer CJLM, Snijders PJF, Brakenhoff RH (2013) Increasing prevalence rates of HPV attributable oropharyngeal squamous cell carcinomas in the Netherlands as assessed by a validated test algorithm. Int J Cancer 132:1565\u20131571","journal-title":"Int J Cancer"},{"key":"5932_CR27","doi-asserted-by":"publisher","first-page":"3775","DOI":"10.1007\/s00520-017-3808-3","volume":"25","author":"S Duman-Lubberding","year":"2017","unstructured":"Duman-Lubberding S, van Uden-Kraan CF, Jansen F, Witte BI, Eerenstein SEJ, van Weert S, de Bree R, Leemans CR, Verdonck-de Leeuw IM (2017) Durable usage of patient reported outcome measures in clinical practice to monitor health related quality of life in head and neck cancer patients. Support Care Cancer 25:3775\u20133783","journal-title":"Support Care Cancer"},{"key":"5932_CR28","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","volume":"85","author":"NK Aaronson","year":"1993","unstructured":"Aaronson NK, Ahmedzai S, Bergman B et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365\u2013376","journal-title":"J Natl Cancer Inst"},{"issue":"Suppl 4","key":"5932_CR29","doi-asserted-by":"publisher","first-page":"S125","DOI":"10.1016\/S0959-8049(01)00448-8","volume":"38","author":"P Fayers","year":"2002","unstructured":"Fayers P, Bottomley A, Group EQoL et al (2002) Quality of life research within the EORTC-the EORTC QLQ-C30. European Organisation for Research and Treatment of Cancer. Eur J Cancer 38(Suppl 4):S125\u2013S133","journal-title":"Eur J Cancer"},{"key":"5932_CR30","doi-asserted-by":"publisher","first-page":"879","DOI":"10.3109\/02841869409098450","volume":"33","author":"K Bjordal","year":"1994","unstructured":"Bjordal K, Ahlner-Elmqvist M, Tollesson E et al (1994) Development of a European Organization for Research and Treatment of Cancer (EORTC) questionnaire module to be used in quality of life assessments in head and neck cancer patients. EORTC Quality of Life Study Group. Acta Oncol 33:879\u2013885","journal-title":"Acta Oncol"},{"key":"5932_CR31","doi-asserted-by":"crossref","unstructured":"ter Wee MM, Lissenberg-Witte BI (2019) A quick guide on how to conduct medical research \u2013 from set-up to publication","DOI":"10.1007\/978-90-368-2248-0"},{"issue":"3","key":"5932_CR32","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.adro.2018.03.002","volume":"3","author":"GD Judy","year":"2018","unstructured":"Judy GD, Green R, Aumer SL, Amdur RJ, Tan X, Sheets N, Weissler M, Zanation A, Patel S, Hackman T, Mendenhall WM, Chera BS (2018) Preservation of swallowing function with de-intensified chemoradiation therapy for HPV-associated oropharyngeal squamous cell carcinoma. Adv Radiat Oncol 3(3):356\u2013365","journal-title":"Adv Radiat Oncol"},{"issue":"11","key":"5932_CR33","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1002\/cncr.31338","volume":"124","author":"BS Chera","year":"2018","unstructured":"Chera BS, Amdur RJ, Tepper JE, Tan X, Weiss J, Grilley-Olson JE, Hayes DN, Zanation A, Hackman TG, Patel S, Sheets N, Weissler MC, Mendenhall WM (2018) Mature results of a prospective study of deintensified chemoradiotherapy for low-risk human papillomavirus-associated oropharyngeal squamous cell carcinoma. Cancer. 124(11):2347\u20132354","journal-title":"Cancer."},{"issue":"3","key":"5932_CR34","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1002\/cncr.30954","volume":"124","author":"JV Hegde","year":"2018","unstructured":"Hegde JV, Shaverdian N, Daly ME, Felix C, Wong DL, Rosove MH, Garst JH, Wang PC, Veruttipong D, Rao S, Fragoso RC, Riess JW, Steinberg ML, Chen AM (2018) Patient-reported quality-of-life outcomes after de-escalated chemoradiation for human papillomavirus-positive oropharyngeal carcinoma: findings from a phase 2 trial. Cancer. 124(3):521\u2013529","journal-title":"Cancer."}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-020-05932-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-020-05932-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-020-05932-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,28]],"date-time":"2021-06-28T03:27:13Z","timestamp":1624850833000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-020-05932-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,17]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["5932"],"URL":"https:\/\/doi.org\/10.1007\/s00520-020-05932-w","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,17]]},"assertion":[{"value":"1 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Verdonck-de Leeuw reported receiving grants from KWF Kankerbestrijding, ZonMw, Bristol-Myers Squibb. No other disclosures were reported.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Medical Ethics Committee of VU University Medical Center.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All participants provided written informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All authors consented to publish this paper.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"N.A.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}